Solubility of oxcarbazepine in eight solvents within the temperature range T = (288.15-308.15) K

被引:23
作者
Nam, Kyungwan [1 ]
Ha, Eun-Sol [2 ]
Kim, Jeong-Soo [3 ]
Kuk, Do-Hoon [2 ]
Ha, Dong-Hyeon [2 ]
Kim, Min-Soo [2 ]
Cho, Cheong-Weon [1 ]
Hwang, Sung-Joo [4 ,5 ]
机构
[1] Chungnam Natl Univ, Coll Pharm, 220 Gung Dong, Daejeon 305764, South Korea
[2] Pusan Natl Univ, Coll Pharm, 2 Busandaehak Ro 63beon Gil, Busan 609735, South Korea
[3] Dong A ST Co Ltd, Yongin 446905, Gyeonggi, South Korea
[4] Yonsei Univ, Coll Pharm, 162-1 Songdo Dong, Inchon 406840, South Korea
[5] Yonsei Univ, Yonsei Inst Pharmaceut Sci, 162-1 Songdo Dong, Inchon 406840, South Korea
基金
新加坡国家研究基金会;
关键词
Oxcarbazepine; Solubility; Correlation; CLINICAL PHARMACOKINETICS; NANOPARTICLES; ABSORPTION; WATER; ACID;
D O I
10.1016/j.jct.2016.09.011
中图分类号
O414.1 [热力学];
学科分类号
摘要
In this study, the solubility of oxcarbazepine in pure methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, acetone, acetonitrile, and tetrahydrofuran was analysed across the temperature range of 288.15-308.15 K under atmospheric pressure by using a solid-liquid equilibrium method. The experimental values obtained data were correlated using the modified Apelblat model at each temperature. The mole fraction solubility of oxcarbazepine in all eight pure solvents increased gradually in a temperature-dependent manner. The highest mole fraction solubility of 3.08 x 10 (3) at 308.15 K was observed for tetrahydrofuran, followed by acetone (1.82 x 10 (3) at 308.15 K), acetonitrile (1.22 x 10 (3) at 308.15 K), methanol (1.11 x 10 (3) at 308.15 K), ethanol (6.17 x 10 (4) at 308.15 K), 1-butanol (6.17 x 10 (4) at 308.15 K), 1-propanol (6.16 x 10 (4) at 308.15 K), and 2-propanol (4.13 x 10 (4) at 308.15 K). The experimental solubility in all solvents correlated well with that calculated using the modified Apelblat equation across the temperature range of (288.15-308.15) K. Therefore, the experimental solubility and correlation equations established in this study could be useful during the crystallization/ purification, pre-formulation, and formulation stages of oxcarbazepine production in laboratories and related industries. (C) 2016 Elsevier Ltd.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 14 条
[1]   Solubilities of o-acetylsalicylic, 4-aminosalicylic, 3,5-dinitrosalicylic, and p-toluic acid, and magnesium-DL-aspartate in water from T = (278 to 348) K [J].
Apelblat, A ;
Manzurola, E .
JOURNAL OF CHEMICAL THERMODYNAMICS, 1999, 31 (01) :85-91
[2]   Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl cellulose [J].
Baek, In-Hwan ;
Kim, Jung-Soo ;
Ha, Eun-Sol ;
Choo, Gwang-Ho ;
Cho, Wonkyung ;
Hwang, Sung-Joo ;
Kim, Min-Soo .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2014, 67 :53-57
[3]   Solubility of three types of benzamide derivatives in toluene, ethyl acetate, acetone, chloroform, methanol, and water at temperatures ranging from 288.15 to 328.15 K at atmospheric pressure [J].
Chen, Jiangang ;
Nan, Guanjun ;
Yang, Rong ;
Zhang, Sanqi ;
Bian, Xiaoli ;
Yang, Guangde .
JOURNAL OF MOLECULAR LIQUIDS, 2015, 204 :137-146
[4]  
FDA Center for drug evaluation and research, CLIN PHARM REV
[5]   Overview of the clinical pharmacokinetics of oxcarbazepine [J].
Flesch, G .
CLINICAL DRUG INVESTIGATION, 2004, 24 (04) :185-203
[6]   Characterization of Supersaturatable Formulations for Improved Absorption of Poorly Soluble Drugs [J].
Gao, Ping ;
Shi, Yi .
AAPS JOURNAL, 2012, 14 (04) :703-713
[7]   Solubility of dronedarone hydrochloride in six pure solvents at the range of 298.15 to 323.15 K [J].
Ha, Eun-Sol ;
Lee, Ye-Ri ;
Kim, Min-Soo .
JOURNAL OF MOLECULAR LIQUIDS, 2016, 216 :360-363
[8]   Fabrication and evaluation of valsartan-polymer-surfactant composite nanoparticles by using the supercritical antisolvent process [J].
Kim, Min-Soo ;
Baek, In-Hwan .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 :5167-5176
[9]   Clinical pharmacokinetics of oxcarbazepine [J].
May, TW ;
Korn-Merker, E ;
Rambeck, B .
CLINICAL PHARMACOKINETICS, 2003, 42 (12) :1023-1042
[10]   Quality by design: screening of critical variables and formulation optimization of Eudragit E nanoparticles containing dutasteride [J].
Park, Se-Jin ;
Choo, Gwang-Ho ;
Hwang, Sung-Joo ;
Kim, Min-Soo .
ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (05) :593-601